Cambrian Bio

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Developer of a portfolio of medicines designed to target the causes of age-related diseases. Cambrian Bio is based in New York, NY and was founded in 2019. Its last reported valuation was $180 million in Aug 2023. It has raised $204 million across 1 recorded round; the latest was a $23.8 million later-stage round in Dec 2025.

Last reported valuation
$180.0M
Oct 2026
Priced at
—
Total raised
$204.1M
Last round
Later Stage VC
Dec 2025

Who backs Cambrian Bio?

41 investors
InvestorType
Alumni VenturesVenture capital
FJ LabsVenture capital
GaingelsVenture capital
RA Capital ManagementAsset manager
Capital FactoryOther
Calm VenturesVenture capital
Sprint VC—
Verve VenturesVenture capital
Catalio Capital ManagementVenture capital
TA VenturesVenture capital
+ 31 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cambrian Bio investors

41 investors are on record for Cambrian Bio, including Alumni Ventures, FJ Labs, Gaingels and RA Capital Management. By type, the record holds 15 venture capital firms, 3 family offices and 2 hedge funds. The later-stage round in Dec 2025 drew 11 investors.

Free account
More of Cambrian Bio with a free account
  • ·The complete investor list: 41 names
  • ·Watch Cambrian Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 41 firms already write checks for companies like Cambrian Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View